Videos / Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Dr Paige Lanyon-Roberts
The New Oral Medications for Obesity – A Practical Guide for GPs
Dr Terri-Lynne South
Oral GLP1s – What GPs Need to Know
Dr Katherine Spira
Menstrual Migraine
Prof Danny Green
GLP1s and Muscle Mass – What Does the Evidence Show?
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
